APH Stock Recent News

I reiterate a Buy rating on Amphenol Corporation stock with a one-year target price of $87 per APH share, driven by strong product demands and robust financial performance. Amphenol posted 33% organic revenue growth and 57.5% adjusted EPS growth, driven by strong market demands in the IT datacom market. The acquisition of LifeSync aligns with Amphenol's M&A strategy, potentially adding $100 million in revenue from the medical device market.

I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. Despite a market sell-off, my investable universe outperformed SPY and SCHD year-to-date, with a loss of -1.83% compared to -5.49% and -4.64%. This month, 17 stocks had valuation rating changes; 10 were upgrades, including Jack Henry & Associates, West Pharma, and EOG Resources, all with strong expected returns.

My Top 15 High-Growth Dividend stocks for April 2025 outperformed SPY and VIG, posting a 0.12% gain versus SPY's -0.87% and VIG's -1.53%. Year-to-date, the Top 15 list returned -0.36%, outperforming VIG's -2.46% and SPY's -5.40%, aiming for a long-term 12% return. The May 2025 Top 15 stocks offer a 1.33% average dividend yield with a 21.25% 5-year dividend growth rate and are 29% undervalued.

The stock rallied more than 8% April 23 after Amphenol sailed past profit and sales expectations for the first quarter.

Does Amphenol (APH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Amphenol (APH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

APH is benefiting from strategic acquisitions and increased demand in AI and aerospace, making it an attractive investment despite a premium valuation.

Amphenol shines in first-quarter 2025 with record Communications Solutions sales, though aerospace weakness and rising capex may challenge its growth trajectory.

Amphenol's Q1 results were exceptional, with earnings and revenues both growing far faster than expected. The company also offered Q2 guidance that was much higher than prior street estimates despite the unsettled macroeconomic picture. Amphenol has meaningful China exposure, and would also face downside if the AI spending boom slows.